Susan O’Brien

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Esteban Braggio

Assistant Professor

Mayo Clinic

UNITED STATES

View details

Nick Pannunzio

Assistant Professor

University of California, Irvine

UNITED STATES

View details

Alexandre Chan

University of California, Irvine

UNITED STATES

View details

Pamela Becker

Professor of Clinical Medicine

University of California, Irvine

UNITED STATES

View details

Deepa Jeyakumar

UNITED STATES

View details

Piyanuch Kongtim

UNITED STATES

View details

Angela G. Fleischman

University of California, Irvine

UNITED STATES

View details

Paolo Ghia

ITALY

View details

Paul M. Barr

University of Rochester

UNITED STATES

View details

William Wierda

Professor of Medicine

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Shawn Griffin

Health Sciences Assistant Clinical Professor

University of California, Irvine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Susan O’Brien

Research Interests

Explore related searches

Contact this professor

Articles (10)

Real-world survival outcomes in first-line ibrutinib-treated patients with high-risk CLL/SLL

HyperCVAD versus pegaspargase‐containing regimens for Hispanic adults with newly diagnosed B‐cell acute lymphoblastic leukemia

A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies

Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID‐19 practice change

B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy

Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemia

CD19‐directed immunotherapy use in KMT2A‐rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switch

Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration Cohorts

Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

Increased incidence of Pegaspargase-induced hypertriglyceridemia and associated pancreatitis observed in the Hispanic adult patient population

Collaborators (11)

Esteban Braggio

Nick Pannunzio

Alexandre Chan

Pamela Becker

Deepa Jeyakumar

Piyanuch Kongtim

Angela G. Fleischman

Paolo Ghia

Paul M. Barr

William Wierda

Shawn Griffin

Make your next move.